For optometrists buying or selling a practice · US & Canada
The Clinic Valuation Tool turns last year’s numbers into a valuation estimate built three ways, weighted the way buyers actually price, and tests the price against the lender’s rules. Answer about 20 plain-English questions. Get a one-page summary in about 10 minutes.
Founding price $199 USD $299 until December 31, 2026 · Excel & Google Sheets · Instant download · Buying? Get it with the Pro Forma for $349
Valuation Summary · builds itself from your numbers
The problem
These three mistakes cost buyers and sellers six figures. The tool is built to catch each one.
Two practices with the same revenue and very different costs get the same price. The tool values profit, and keeps the revenue rule only as a check.
A seller who pays himself little looks very profitable. The tool pays a fair wage for the owner’s patient days before it values anything.
Since October 2026, SBA lenders test a purchase on last year’s real numbers. The tool finds the highest price that passes.
Free · 30 seconds
A rough range from one method. Good enough to know if a listing is in the ballpark. Not good enough to sign anything.
Runs in your browser. Nothing you type is sent to us or saved.
Rough range (SDE method)
–
Small-practice SDE multiples only (US 2.0x–3.5x, Canada 1.75x–3.0x). It skips the asset floor, the EBITDA method, practice size, quality adjustments and the lender test. The full tool doesn’t.
The full tool weighs three methods, adjusts for lease, trend, optical and owner dependence, and tells you the highest price a lender would likely back.
Get the Valuation Tool: $199What’s inside
Quick Start asks about 20 plain-English questions, most of them dropdowns, and shows the verdict as you type. Every multiple and assumption stays editable, with its source listed.


Two modes
“What should I ask for?”
“Is this price fair, and can I finance it?”
Why this one
| Rule of thumb | Formal appraisal | Valuation Tool | |
|---|---|---|---|
| Uses profit, not just revenue | — | ✓ | ✓ |
| Three methods, weighted by practice size | — | ✓ | ✓ |
| Tests the price against the lender’s rules | — | Sometimes | ✓ |
| Rerun it for every offer and counter-offer | ✓ | Billed again | ✓ |
| Ready in about 10 minutes | ✓ | Weeks | ✓ |
| Price | Free | Often $3,000–$10,000 | $199 once |
Appraisal fee range: published small-business valuation fees, 2026. Get a formal appraisal before you sign; use this tool to know where you stand first.
Buying a practice?
The bundle adds the Clinic Pro Forma: a lender-ready 5-year plan at the price you agree. The two tools use the same loan rules, so their numbers line up.
$349 $398
Save $49 today · $499 from January 1 (save $99)
See the bundle
Who built it
I've started, sold and still own multiple optometry clinics, and consulted on more than 100 clinics. Before optometry school I built and sold a business making plug-and-play spreadsheets. These are the tools I use on my own deals.
— Dr. Davinder Sidhu, OD
Founding price · ends December 31, 2026
A practice sale is usually the biggest number in an optometrist’s career. Five percent either way on a $1M practice is $50,000. Know your number before anyone else sets it for you.
Buying? Get the Valuation Tool and the Pro Forma together for $349.
$199 USD, one time
$299 from January 1, 2027
Secure checkout by Stripe · Instant download · Price in USD, sales tax added at checkout where required · For one owner’s use · All sales final, see terms
Questions
No. It gives you a valuation estimate: a range built from three standard methods, using published market multiples. Use it to set an asking price, check an offer and prepare for your broker, lender or appraiser. A formal appraisal is still worth getting before you sign.
Yes. Seller mode gives you a suggested asking price: the top of your estimated range, capped at what a buyer could actually finance. It also shows the levers that raise your value, with the dollar effect of each.
Yes. Buyer mode tells you whether the asking price sits below, inside or above the estimated range, and whether last year's cash covers the loan at that price. If you're buying, the bundle adds the Clinic Pro Forma so you can plan the next five years too.
Because each answers a different question. The asset floor is what the equipment and inventory are worth. The SDE method is how most doctor-to-doctor sales are priced. The EBITDA method is how investor groups price. The tool weights them by practice size and never averages in the floor, so you don't get a lowball.
Since October 1, 2026, SBA lenders judge a practice purchase on last year's real numbers, not projections, and want the cash to cover the loan payments at least 1.25 times. The tool runs that test at your price and works out the highest price a lender would likely back. Canadian banks use similar coverage tests.
Yes. Pick Canada and it uses Canadian multiples, a Canadian doctor wage and Canadian interest-rate defaults. Little Canadian sale data is published, so the Canadian multiples are a practitioner estimate, and the tool says so.
Last year's collections, net profit, the owner's pay, and interest and depreciation from the tax return. About 20 plain-English questions in total, most of them dropdowns. The Get Your Numbers tab includes an email you can send to the seller or your accountant.
Checkout is secure through Stripe, priced in US dollars. Canadian cards work fine. The moment payment goes through, you land on your download page. Bookmark it. Your receipt shows the purchase as sold through Link, Stripe's checkout.
Yes. The founding price of $199 USD ends December 31, 2026 at 11:59 pm Pacific. From January 1, 2027 it's $299.
No. It's an instant digital download, so all sales are final. Try the free quick worth check on this page first. If the file won't open or something is broken, email hello@thegenuwineod.com and I'll fix it.
Whether you’re listing or making an offer, walk in with a range you understand and a price a bank will finance.
Get the Valuation Tool: $199A valuation estimate for planning and education. Not an appraisal, and not financial, lending, legal or tax advice. Multiples come from published market sources; The Genuwine OD is not affiliated with or endorsed by any lender, broker or data provider.